These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32593708)

  • 61. ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/β-catenin pathway.
    Tao L; Zhu Y; Gu Y; Zheng J; Yang J
    Eur J Pharmacol; 2019 Sep; 858():172476. PubMed ID: 31228451
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
    Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
    Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients.
    Savio AJ; Daftary D; Dicks E; Buchanan DD; Parfrey PS; Young JP; Weisenberger D; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
    BMC Cancer; 2016 Feb; 16():113. PubMed ID: 26884349
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis.
    Zhang J; Tsoi H; Li X; Wang H; Gao J; Wang K; Go MY; Ng SC; Chan FK; Sung JJ; Yu J
    Gut; 2016 Sep; 65(9):1482-93. PubMed ID: 26071132
    [TBL] [Abstract][Full Text] [Related]  

  • 65. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
    Bong YS; Assefnia S; Tuohy T; Neklason DW; Burt RW; Ahn J; Bueno De Mesquita PJ; Byers SW
    Oncotarget; 2016 Dec; 7(49):80508-80520. PubMed ID: 27768599
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of ICAT as an APC Inhibitor, Revealing Wnt-Dependent Inhibition of APC-Axin Interaction.
    Ji L; Lu B; Wang Z; Yang Z; Reece-Hoyes J; Russ C; Xu W; Cong F
    Mol Cell; 2018 Oct; 72(1):37-47.e4. PubMed ID: 30197296
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
    Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
    J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab.
    Lee SK; Cho YH; Cha PH; Yoon JS; Ro EJ; Jeong WJ; Park J; Kim H; Il Kim T; Min DS; Han G; Choi KY
    Exp Mol Med; 2018 Nov; 50(11):1-12. PubMed ID: 30459318
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells.
    Huang TC; Lee PT; Wu MH; Huang CC; Ko CY; Lee YC; Lin DY; Cheng YW; Lee KH
    PLoS One; 2017; 12(8):e0181034. PubMed ID: 28859077
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors.
    Szvicsek Z; Oszvald Á; Szabó L; Sándor GO; Kelemen A; Soós AÁ; Pálóczi K; Harsányi L; Tölgyes T; Dede K; Bursics A; Buzás EI; Zeöld A; Wiener Z
    Cell Mol Life Sci; 2019 Jun; 76(12):2463-2476. PubMed ID: 31028424
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Co‑expression of Axin and APC gene fragments inhibits colorectal cancer cell growth via regulation of the Wnt signaling pathway.
    Xu M; Liu X; Xu Y; Zhu S; Gao Y
    Mol Med Rep; 2017 Oct; 16(4):3783-3790. PubMed ID: 28731177
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.
    Yedid N; Kalma Y; Malcov M; Amit A; Kariv R; Caspi M; Rosin-Arbesfeld R; Ben-Yosef D
    BMC Cancer; 2016 Dec; 16(1):952. PubMed ID: 28010732
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A kinetic model to study the regulation of β-catenin, APC, and Axin in the human colonic crypt.
    Emerick B; Schleiniger G; Boman BM
    J Math Biol; 2017 Nov; 75(5):1171-1202. PubMed ID: 28271271
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of Wnt and β-catenin Expression in Advanced Colorectal Cancer.
    Yoshida N; Kinugasa T; Ohshima K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y
    Anticancer Res; 2015 Aug; 35(8):4403-10. PubMed ID: 26168479
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
    Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
    Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
    [TBL] [Abstract][Full Text] [Related]  

  • 79. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
    Cho YH; Cha PH; Kaduwal S; Park JC; Lee SK; Yoon JS; Shin W; Kim H; Ro EJ; Koo KH; Park KS; Han G; Choi KY
    Oncotarget; 2016 Dec; 7(49):81727-81740. PubMed ID: 27835580
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway.
    Jeong WJ; Ro EJ; Choi KY
    NPJ Precis Oncol; 2018; 2(1):5. PubMed ID: 29872723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.